skip to Main Content

RSNA News: PI-RADS v2 Effective in Predicting Prostate Cancer

Experts, Clare M. Tempany-Afdhal, MD, Sung Yoon Park, MD, PhD, and Jelle Barentsz, MD, PhD, weigh in on PI-RADS v2 — a simplified scoring system focusing on the detection and exclusion of clinically significant prostate cancer.

Back To Top